Lobbying

Limbix Health's latest lobbying report covers Q3 2023, at $10K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.

Limbix Health

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Limbix Health lobbying by quarter
Limbix Health lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$10K1
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medicare and Medicaid$70K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)4 reports
  • Health & Human Services, Dept of (HHS)4 reports
  • HOUSE OF REPRESENTATIVES4 reports
  • SENATE4 reports

Firms it paid

Firm
Mason Street Consulting$70K4 quarters

Former officials lobbying for it

Former position
SUSAN S ZOOKLegislative Assistant, Senator Mike CrapoQ3 2023

Lobbying reports

Filed by
23/10/19for Q3 2023Mason Street Consulting$10K
23/07/16for Q2 2023Mason Street Consulting$20K
23/04/07for Q1 2023Mason Street Consulting$20K
23/01/14for Q4 2022Mason Street Consulting$20K